A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome.Matthew S. Davids, Philip A. Thompson, Josie Montegaard et al.|Journal of Clinical Oncology|2020Cited by 12